| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
REPRODUCTION-DEVELOPMENT |
Department of Endocrinology and Reproduction (F.F.G.R.), Erasmus University, 3000 DR Rotterdam, The Netherlands; Scott Department of Urology (S.R.K.), Huffington Center on Aging, and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030; and Department of Chemical Endocrinology (P.N.S.), University Medical Center Sint Radboud, 6500 HB Nijmegen, The Netherlands
Address all correspondence and requests for reprints to: F. F. G. Rommerts, Department of Endocrinology and Reproduction, Erasmus University, dr. Molewaterplein 50, 3000 DR Rotterdam, The Netherlands. E-mail: rommerts{at}endov.fgg.eur.nl
In virtually all studies with MA-10 cells, progesterone RIAs have
been used to measure steroid synthesis. To test whether progesterone is
a stable end product, we investigated the metabolism of added tritiated
progesterone and pregnenolone in MA-10 cells over a period of 3 h.
Steroids were then extracted, separated by HPLC, and identified by
GC/MS. We found that more than 70% of radiolabeled steroids were
converted to at least five different metabolites. A major metabolite
(40%) was 5
-pregnan-3
or 3ß-ol-20one. Similar studies, using
radiolabeled T, demonstrated conversion to dihydrotestosterone and two
forms of 5
-androstane-diols. These data indicate the presence of
active 5
-reductase and 3
- and/or 3ß-hydroxysteroid
dehydrogenase activities in MA-10 cells.
Because these results suggest that progesterone is an unstable end product, to gauge the level of active metabolism, we incubated cells in the presence of inhibitors of pregnenolone metabolism and assessed pregnenolone levels by RIA. We discovered that basal levels of steroidogenesis in MA-10 cells were considerably higher than previously estimated. Moreover, dibutyryl cAMP-stimulated steroid production was linear over more than 13 h, in contrast to previous findings that measured progesterone levels. Other consequences of inaccurate assessment of steroidogenic activity in MA-10 cells because of the application of the progesterone assay are discussed.
This article has been cited by other articles:
![]() |
B. Costa, S. Pini, P. Gabelloni, E. Da Pozzo, M. Abelli, L. Lari, M. Preve, A. Lucacchini, G. B. Cassano, and C. Martini The Spontaneous Ala147Thr Amino Acid Substitution within the Translocator Protein Influences Pregnenolone Production in Lymphomonocytes of Healthy Individuals Endocrinology, December 1, 2009; 150(12): 5438 - 5445. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R Manna, Y. Jo, and D. M Stocco Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling J. Endocrinol., April 1, 2007; 193(1): 53 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jo and D. M. Stocco Regulation of Steroidogenesis and Steroidogenic Acute Regulatory Protein in R2C Cells by DAX-1 (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X Chromosome, Gene-1) Endocrinology, December 1, 2004; 145(12): 5629 - 5637. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schwarzenbach, G. Chakrabarti, H. J. Paust, and A. K. Mukhopadhyay Gonadotropin-Mediated Regulation of the Murine VEGF Expression in MA-10 Leydig Cells J Androl, January 1, 2004; 25(1): 128 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schwarzenbach, P. R. Manna, D. M. Stocco, G. Chakrabarti, and A. K. Mukhopadhyay Stimulatory Effect of Progesterone on the Expression of Steroidogenic Acute Regulatory Protein in MA-10 Leydig Cells Biol Reprod, March 1, 2003; 68(3): 1054 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation Endocrinology, September 1, 2002; 143(9): 3351 - 3360. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |